Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Neurocrine Biosciences, Inc.    NBIX

NEUROCRINE BIOSCIENCES, INC.

(NBIX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société NEUROCRINE BIOSCIENCES, IN
05/26NEUROCRINE BIOSCIENCES : to Present at the Jefferies Virtual Healthcare Conferen..
PR
05/21NEUROCRINE BIOSCIENCES INC : Change in Directors or Principal Officers, Submissi..
AQ
05/14NEUROCRINE BIOSCIENCES : to Present at the RBC Capital Markets 2020 Global Healt..
PR
05/14NEUROCRINE BIOSCIENCES : to Present Data from its Movement Disorder Portfolio on..
AQ
05/06NEUROCRINE BIOSCIENCES : Management's Discussion and Analysis of Financial Condi..
AQ
05/06NEUROCRINE BIOSCIENCES INC : Results of Operations and Financial Condition, Fina..
AQ
05/06NEUROCRINE : 1Q Earnings Snapshot
AQ
05/06NEUROCRINE BIOSCIENCES : Reports First Quarter 2020 Financial Results
PR
05/05NEUROCRINE BIOSCIENCES : to Present at Bank of America Merrill Lynch Health Care..
PR
04/27NEUROCRINE BIOSCIENCES : Announces FDA Approval of Once-Daily ONGENTYS® (opicapo..
PU
04/27NEUROCRINE BIOSCIENCES : Announces FDA Approval of Once-Daily ONGENTYS® (opicapo..
PR
04/15NEUROCRINE BIOSCIENCES : Announces Conference Call and Webcast of First Quarter ..
PR
04/09NEUROCRINE BIOSCIENCES INC : Change in Directors or Principal Officers (form 8-K..
AQ
04/06NEUROCRINE BIOSCIENCES : Provides COVID-19 Business Update
AQ
04/06VOYAGER THERAPEUTICS : Provides Update on the RESTORE-1 Parkinson's Disease Tria..
AQ
04/03NEUROCRINE BIOSCIENCES : Provides COVID-19 Business Update
PR
02/25NEUROCRINE BIOSCIENCES : to Present at Cowen 40th Annual Health Care Conference
PR
02/07NEUROCRINE BIOSCIENCES : Management's Discussion and Analysis of Financial Condi..
AQ
02/05NEUROCRINE BIOSCIENCES INC : Results of Operations and Financial Condition, Fina..
AQ
02/04NEUROCRINE : 4Q Earnings Snapshot
AQ
02/04NEUROCRINE BIOSCIENCES INC : Results of Operations and Financial Condition, Chan..
AQ
02/04NEUROCRINE BIOSCIENCES : Reports Fourth Quarter and Full-Year 2019 Financial Res..
PR
02/03NEUROCRINE BIOSCIENCES : Announces Appointment of Shalini Sharp to Board of Dire..
PR
01/20NEUROCRINE BIOSCIENCES : Announces Conference Call and Webcast of Fourth Quarter..
PR
01/13NEUROCRINE BIOSCIENCES : and Idorsia Amend Option Agreement to License Novel Tre..
AQ
01/13NEUROCRINE BIOSCIENCES : Provides Preliminary Fourth Quarter and Full-Year 2019 ..
AQ
01/13NEUROCRINE BIOSCIENCES INC : Results of Operations and Financial Condition, Fina..
AQ
01/07NEUROCRINE BIOSCIENCES : to Present at the 38th Annual J.P. Morgan Healthcare Co..
AQ
01/06NEUROCRINE BIOSCIENCES : to Present at the 38th Annual J.P. Morgan Healthcare Co..
PR
2019NEUROCRINE BIOSCIENCES : to Present at Evercore ISI 2nd Annual HealthCONx Confer..
PR
2019NEUROCRINE BIOSCIENCES : Phase III Clinical Study of Valbenazine for Chorea in H..
AQ
2019NEUROCRINE BIOSCIENCES : Publishes Long-Term INGREZZA® (valbenazine) Data in the..
PR
2019NEUROCRINE BIOSCIENCES : to Present at Upcoming Healthcare Conferences
PR
2019NEUROCRINE : 3Q Earnings Snapshot
AQ
2019NEUROCRINE BIOSCIENCES : Management's Discussion and Analysis of Financial Condi..
AQ
2019NEUROCRINE BIOSCIENCES INC : Results of Operations and Financial Condition, Fina..
AQ
2019NEUROCRINE BIOSCIENCES : Reports Third Quarter 2019 Financial Results
PR
2019NEUROCRINE BIOSCIENCES : Announces Conference Call and Webcast of Third Quarter ..
PR
2019NEUROCRINE BIOSCIENCES : Presents New Data Analyses Demonstrating Long-Term effe..
AQ
2019NEUROCRINE BIOSCIENCES : Presents New Data Analyses Demonstrating Long-Term Effe..
PR
2019NEUROCRINE BIOSCIENCES : to Present Data Analyses Demonstrating the Long-Term Ef..
AQ
2019NEUROCRINE BIOSCIENCES : to Present Data Analyses Demonstrating the Long-Term Ef..
PR
2019NEUROCRINE BIOSCIENCES : Appoints David W. Boyer as Chief Corporate Affairs Offi..
PR
2019NEUROCRINE BIOSCIENCES : to Present Data on INGREZZA for Tardive Dyskinesia Opic..
AQ
2019NEUROCRINE BIOSCIENCES : to Present Data on INGREZZA® (valbenazine) for Tardive ..
PR
2019NEUROCRINE BIOSCIENCES INC : Change in Directors or Principal Officers (form 8-K..
AQ
2019NEUROCRINE BIOSCIENCES : Announces Appointment of Leslie V. Norwalk to Board of ..
PR
2019NEUROCRINE BIOSCIENCES : to Present at Upcoming Healthcare Conferences
PR
2019ABBVIE : Submits New Drug Application to US FDA for Investigational Elagolix for..
AQ
2019NEUROCRINE BIOSCIENCES : Management's Discussion and Analysis of Financial Condi..
AQ
2019NEUROCRINE : 2Q Earnings Snapshot
AQ
2019NEUROCRINE BIOSCIENCES INC : Results of Operations and Financial Condition, Fina..
AQ
2019NEUROCRINE BIOSCIENCES : Reports Second Quarter 2019 Financial Results
PR
2019NEUROCRINE BIOSCIENCES : Announces FDA Acceptance of New Drug Application for Op..
PR
2019NEUROCRINE BIOSCIENCES : Announces Conference Call and Webcast of Second Quarter..
PR
2019NEUROCRINE BIOSCIENCES : to Present Data on INGREZZA® (valbenazine) and Opicapon..
PR
2019NEUROCRINE BIOSCIENCES : to Present at Goldman Sachs 40th Annual Global Healthca..
PR
2019NEUROCRINE BIOSCIENCES : to Present at Jefferies 2019 Global Healthcare Conferen..
PR
2019NEUROCRINE BIOSCIENCES : to Present at Bank of America Merrill Lynch Health Care..
PR
2019NEUROCRINE BIOSCIENCES : to Present Data Analyses on INGREZZA® (valbenazine) and..
PU
2019NEUROCRINE BIOSCIENCES : Reports First Quarter 2019 Financial Results
PR
2019NEUROCRINE BIOSCIENCES : Announces Conference Call and Webcast of First Quarter ..
PR
2019NEUROCRINE BIOSCIENCES : Reports Positive Interim Results from Phase II Study of..
PR
2019NEUROCRINE BIOSCIENCES : to Present at Upcoming Healthcare Conferences
PR
2019NEUROCRINE BIOSCIENCES : Reports Fourth Quarter and Year-End 2018 Financial Resu..
PR
2019NEUROCRINE BIOSCIENCES : New INGREZZA® (valbenazine) Analysis Published in the J..
PR
2019NEUROCRINE BIOSCIENCES : Announces Conference Call and Webcast of Fourth Quarter..
PR
2019NEUROCRINE BIOSCIENCES : Provides Preliminary Fourth Quarter and Full-Year 2018 ..
PU
2019NEUROCRINE BIOSCIENCES : to Present at the 37th Annual J.P. Morgan Healthcare Co..
PR
2018NEUROCRINE BIOSCIENCES : Announces Topline Data from Phase IIb T-Force GOLD Stud..
PR
2018NEUROCRINE BIOSCIENCES : to Present at the Jefferies 2018 London Healthcare Conf..
PR
2018NEUROCRINE BIOSCIENCES : Reports Third Quarter 2018 Financial Results
PR
2018NEUROCRINE BIOSCIENCES : to Present New Data Analyses on the Long-Term Effects o..
PR
2018NEUROCRINE BIOSCIENCES : Announces Conference Call and Webcast of Third Quarter ..
PR
2018NEUROCRINE BIOSCIENCES : and Jnana Therapeutics Enter Strategic Collaboration to..
PR
1  2  3  4  5  6Next
Upcoming event on NEUROCRINE BIOSCIENCES, IN